207_Combined course Presentations
Hybrid study: SBRT with concurrent chemoradiation
Toxicity profile using CTCAE v4
DVH parameters
Conclusions
A Hybrid treatment of SBRT of the primary tumor combined with fractionated radiotherapy on the lymph nodes with concurrent chemotherapy is feasible.
This phase I trial (NCT01933568) is currently accruing and no unexpected toxicity has been observed thus far.
Courtesy of J. Belderbos
Made with FlippingBook